• Users Online: 293
  • Print this page
  • Email this page

Current Issue

January-March 2019| Vol 2| Issue 1


Glioma special issue introduction

In the past decade, cancer immunotherapy has emerged from experimental protocols in select pathologies to a mainstay of frontline cancer therapy that has drastically improved outcomes for thousands of...


Importance of iatrogenic immunosuppression in the treatment of patients with high-grade glioma with immunotherapy

Treatment-related lymphopenia is a poor prognostic factor for overall survival in patients with high-grade glioma and predicts suboptimal response to immune therapies. Immunotherapy is conceptually an...


Combination of oncolytic viruses and immune checkpoint inhibitors in glioblastoma

Glioblastoma is associated with poor prognosis with a mean survival of 15 months after diagnosis. The current standard of care includes surgery, radiation, and temozolomide with the use of tumor-treat...


Immune checkpoint modulation: Tenets and implications in glioblastoma

Glioblastoma (GBM) is the most common primary central nervous system tumor, and despite advances made in traditional chemotherapy and radiation, it continues to carry a poor prognosis. The discovery...


Gamma-delta T cells in glioblastoma immunotherapy

Conventional immunotherapy in the treatment of glioblastoma (GBM) has essentially produced no significant advantage over the use of chemotherapeutic drugs. A strongly immunosuppressive tumor microenvi...

View All Articles in the Current Issue

Glioma, a publication of Chinese Society of Neuro-Oncology (CSNO), is a peer-reviewed print + online Quarterly journal.

Features of Manuscript Management System

  • Online submission
  • Wider visibility through open access
  • Higher impact
  • Prompt review

Abstracting and Indexing Information

The journal is registered with the following abstracting partners:
Baidu Scholar, CNKI (China National Knowledge Infrastructure), EBSCO Publishing's Electronic Databases, Ex Libris – Primo Central, Google Scholar, Hinari, Infotrieve, Netherlands ISSN center , ProQuest, TdNet, Wanfang Data

The journal is indexed with, or included in, the following: